Minovia Therapeutics Ltd.: Clinical Trials

4 recruiting, 1 active not recruiting, 1 completed, 1 withdrawn. 3 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	3	Completed 1, Recruiting 1, Withdrawn 1
Phase 2	2	Completed 1, Recruiting 1

Follow Minovia Therapeutics Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the MNV-201 in Patients With Low Risk MDS MNV-201 (Autologous CD34+ Cells Enriched with allogenic Placenta Derived Mitochondria) - Myelodysplastic Syndromes	Phase 1	Recruiting	Minovia Therapeutics Ltd.	15	2024-05-27	2025-10-01
Collection of Blood and Skin Samples From Patients With Primary Mitochondrial Diseases and Healthy Volunteers Primary Mitochondrial Diseases		Recruiting	Minovia Therapeutics Ltd.	100	2024-05-12	2025-10-01
Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS) MNV-201 - Mitochondrial Diseases, Pearson Syndrome	Phase 2	Recruiting	Minovia Therapeutics Ltd.	6	2023-07-31	2026-10-13
Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome Blood test - Myelodysplastic Syndromes		Active not recruiting	Minovia Therapeutics Ltd.	100	2023-02-09	2026-10-13
A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion Bone Marrow mobilization, Apheresis, MNV-BM-PLC infusion - Primary Mitochondrial Diseases	Phase 1	Withdrawn	Minovia Therapeutics Ltd.		2022-03-01	2025-06-22
A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome CD34+ cells enriched with MNV-BLD - Mitochondrial Diseases, Pearson Syndrome	Phase 1 / Phase 2	Completed	Minovia Therapeutics Ltd.	7	2019-02-13	2021-08-31
Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies Pregnancy Related		Recruiting	Minovia Therapeutics Ltd.	300	2018-12-01	2026-10-08

Conditions studied

Mitochondrial Diseases (2)  ·  Myelodysplastic Syndromes (2)  ·  Rare Diseases (2)  ·  VLCAD deficiency (2)  ·  Anemia (1)

Interventions

Blood Component Removal (1)  ·  Hematologic Tests (1)

Countries

Israel (7)